FULVESTRANT for Breast cancer: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 3,352 adverse event reports in the FDA FAERS database where FULVESTRANT was used for Breast cancer.
Most Reported Side Effects for FULVESTRANT
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 3,221 | 18.2% | 486 | 402 |
| Fatigue | 1,840 | 10.4% | 183 | 460 |
| Death | 1,677 | 9.5% | 1,676 | 143 |
| Metastases to bone | 1,525 | 8.6% | 96 | 208 |
| Nausea | 1,510 | 8.5% | 217 | 605 |
| Neutropenia | 1,486 | 8.4% | 141 | 313 |
| Metastases to liver | 1,241 | 7.0% | 178 | 153 |
| Breast cancer metastatic | 1,165 | 6.6% | 252 | 204 |
| Diarrhoea | 1,163 | 6.6% | 97 | 399 |
| Dyspnoea | 858 | 4.9% | 132 | 382 |
| Neoplasm progression | 853 | 4.8% | 153 | 112 |
| Asthenia | 827 | 4.7% | 145 | 280 |
| Pain | 825 | 4.7% | 91 | 263 |
| Vomiting | 814 | 4.6% | 161 | 406 |
| Drug ineffective | 749 | 4.2% | 97 | 134 |
Other Indications for FULVESTRANT
Breast cancer metastatic (4,570)
Product used for unknown indication (2,741)
Breast cancer female (1,292)
Hormone receptor positive her2 negative breast cancer (823)
Hormone receptor positive breast cancer (228)
Invasive ductal breast carcinoma (209)
Breast cancer stage iv (185)
Her2 positive breast cancer (176)
Metastases to bone (170)
Breast cancer recurrent (155)
Other Drugs Used for Breast cancer
TRASTUZUMAB (15,522)
PALBOCICLIB (13,075)
DOCETAXEL (11,735)
PACLITAXEL (10,215)
LETROZOLE (9,332)
CYCLOPHOSPHAMIDE (8,826)
PERTUZUMAB (7,532)
RIBOCICLIB (6,953)
CAPECITABINE (5,767)
EPIRUBICIN (5,444)